The Orthopilot® 2 Navigation Platform is a system for computer-aided navigation of surgical instruments. Its purpose is to optimally position endoprosthesis in arthroplasty such as the Search Evolution Knee system and the Gem Knee system in the patient. It aids the surgeon in accurately positioning the cutting guides, drills and reamers for total endoprosthesis replacement surgery and provides intraoperative measurements of bone alignment. It indicates optimized angles and positions for implant placement. (Does not include an indication for High Tibial Osteotomy (HTO) module).

Device Description

Orthopilot® 2 Navigation Platform uses transmitters that are mounted to the patients bones, or are flexible to palpate landmarks and a camera to monitor the spatial location of those transmitters in relation to each other and the medical instruments. These locations are used to locate the centers of rotation of the femur head, ankle, knee. These measurements allow for greater accuracy than mechanical methods of ascertaining implantation sites and positions.

AI/ML Overview

The provided text does not contain any information about acceptance criteria or a study proving the device meets acceptance criteria.

The document is a 510(k) premarket notification for the Orthopilot 2 Navigation Platform. It focuses on regulatory compliance, device description, indications for use, and substantial equivalence to previously cleared devices.

Therefore, I cannot fulfill your request for the following information based on the provided text:

A table of acceptance criteria and the reported device performance
Sample size used for the test set and the data provenance
Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Adjudication method for the test set
If a multi-reader multi-case (MRMC) comparative effectiveness study was done, and its effect size
If a standalone performance (i.e. algorithm only without human-in-the-loop performance) was done
The type of ground truth used
The sample size for the training set
How the ground truth for the training set was established

The document primarily states that the Orthopilot 2 Navigation Platform complies with general safety and electromagnetic compatibility standards (IEC 60601-1, IEC 60601-1-2, CAN/CSA-C22.2 No. 601.1-M90), but these are performance standards for electrical and medical equipment safety, not clinical performance acceptance criteria for the navigation system's accuracy or efficacy in positioning endoprostheses. The FDA's letter also indicates that no applicable performance standards have been promulgated under Section 514 specifically for this device system.

Summary

{0}------------------------------------------------

K013569 1/2

Orthopilot 2 Navigation Platform

APR 0 4 2002

Summary of Safety and Effectiveness Information	AESCULAP®, INC.
Premarket Notification, Section 510(k)	OCTOBER 23, 2001

Regulatory Authority: Safe Medical Devices Act of 1990, 21 CFR 807.92

Trade Name: Orthopilot® 2

Common Name(s): Orthopilot 2 Navigation Platform

Classification Name(s): Stereotaxic Instrument

Establishment Name & Registration Number:

Aesculap®, Inc. Name: Number: 2916714

Classification: 21 CFR Section 882.5550

Device Class: Class II Classification Panel: Neurology Product Code(s): HAW

Applicant Name & Address: Aesculap®, Inc. 3773 Corporate Parkway Center Valley, PA 18034

Company Contact:

Georg Keller Requlatory Affairs Manager 800/258-1946 x 5073 (phone) 610/791-6882 (fax)

Indications for Use

The Orthopilot 2 Navigation Platform is a system for computer-aided navigation of surgical instruments. Its purpose is to optimally position endoprosthesis in arthroplasty such as the Search Evolution Knee system and the Gem Knee system in the patient. It aids the surgeon in accurately positioning the cutting guides, drills and reamers for total endoprosthesis replacement surgery and provides intraoperative measurements of bone alignment. It indicates optimized and positions for implant placement. (Does not include an indication for High Tibial Osteotomy (HTO) module).

Device Description

{1}------------------------------------------------

K015569 2/2

Performance Standards (Section 514 compliance):

No applicable performance standards have been promulgated under Section 514 of the Food, Drug and Cosmetic Act for this device system. However, Aesculap's Orthopilot® 2 Navigation Platform complies with the following standards, which appear, on the FDA List of Recognized Consensus Standards:

International Electrotechnical Commission; Medical Electrical IEC 60601-1 Equipment, Part 1: General Requirements for Safety.
International Electrotechnical Commission; Medical Electrical IEC 60601-1-2 Equipment, General Requirements for Safety: Electromagnetic Compatibility - Requirements and Tests.

In addition, the Orthopilot® 2 Navigation Platform meets the requirements of the following Canadian Standard Association standard.

CAN/CSA- C22.2	Medical Electrical Equipment, Part 1: General
No. 601.1-M90	Requirements for Safety

Labeling:

The Aesculap's Orthopilot 2 Navigation Platform discussed in this premarket notification will be manufactured and labeled with the Aesculap® logo. The system will be marketed exclusively to healthcare facilities and physicians.

Substantial Equivalence:

Aesculap's Orthopilot 2 Navigation Platform is substantially equivalent to existing devices cleared by FDA. They are as follows:

Orthopilot® (K003347) .
Stryker Navigation System-Knee Module (K010204) .
Brainlab Vector Vision Knee (K010612) .
Brainlab Vector Vision Hip (K010602) .

{2}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, a symbol often associated with healthcare. The symbol is composed of three curved lines that form a shape similar to a bird or a stylized human figure.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Aesculap, Inc. · Mr. Georg Keller Regulatory Affairs Manager 3773 Corporate Parkway Center Valley, Pennsylvania 18034

Re: K013569 Trade Name: Orthopilot 2 Regulation Number: 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: II Product Code: HAW Dated: January 22, 2002 Received: January 23, 2002

APR 0 4 2002

Dear Mr. Keller:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{3}------------------------------------------------

Page 2 - Mr. Georg Keller

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus. permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, (Misbranding by reference to premarket notification( (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 6382041 or (301) 4436597 or at its Internet address HYPERLINK http://www.fda.gov/cdrh/dsma/dsmamain.html http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours.

Miriam C. Provost

For Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

B. INDICATIONS FOR USE STATEMENT

Page 1 of 1

510(k) Number:

Ka13569

Device Name:

Orthopilot® 2 Navigation Platform

Indication for Use:

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Muriam C. Phrost

(Division Sign-Off) Division of General, Restorative and Neurological Devices

510(k) Number K013569

or Over-the-Counter Use Prescription Use

Regulation Number and Section

§ 882.4560 Stereotaxic instrument.

(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).